Logo

American Heart Association

  9
  0


Final ID: MDP1493

Different Determinants of Thrombotic Events in Transthyretin Cardiac Amyloidosis versus Other Left Ventricular Hypertrophy Phenotypes

Abstract Body (Do not enter title and authors here): Background: Thrombotic events (TE) are more frequent in cardiac amyloidosis (CA) as compared to other phenotypes of left ventricular hypertrophy (LVH) the absence of regional wall motion abnormalities.
Aim: We sought to investigate the determinants of TE in patients with transthyretin cardiac amyloidosis (ATTR-CA).
Method: Among subjects referred to our CA center those with LVH (interventricular septum thickness ≥ 1.2 cm) were included consecutively. Patients with hypertrophic obstructive cardiomyopathy, light chain CA or mitral valve disease were excluded. All subjects underwent echocardiography with speckle tracking imaging, Tc-99m pyrophosphate scintigraphy, serum and urine immune electrophoresis as per the registry protocol. Cardiac magnetic resonance imaging and endomyocardial biopsy were performed for diagnosis as needed. Control group consisted of subjects with non-amyloidosis LVH. Patients were followed-up over 5 years for TE (ischemic stroke, peripheral emboli, intracardiac thrombus).
Results: In all, 149 ATTR-CA and 133 LVH patients (24 non-obstructive hypertrophic cardiomyopathy, 18 aortic stenosis, 91 hypertensive cardiomyopathy) were studied. Maximal LA volume index (LAVImax) did not increase significantly with atrial fibrillation (AF) in the ATTR-CA group, unlike in the LVH group. In the ATTR-CA group left atrial reservoir strain (LASr) was significantly reduced (10.2±4.8 vs 16.1±8.1, p<0.001) and LA stiffness (LASr/E/e’) significantly increased (2.4±1.6 vs 1.3±1.0, p<0.001) as compared to the LVH group. CHA2DS2-VASc was similar in both groups. (p=0.376). The comparison of patients with and without TE is presented in the table (Figure 1). In the ATTR-CA group, a higher percentage of patients (74%) were in or developed new AF versus the LVH group (55%) (p<0.001). In the LVH group, AF (hazard ratio (HR): 10, 95% confidence interval (CI), 2.4-42.2, p=0.024) and CHA2DS2-VASc (HR: 3.6, 95% CI, 1.52-8.48, p=034) were the independent determinants of TE. Whereas, in the ATTR-CA group LASr (HR: 0.85, 95% CI, 0.74-0.97, p=0.021) and LA stiffness (HR: 1.54, 95% CI, 1.18-1.99, p=0.001) emerged as independent determinants of TE among relevant covariates (AF, CHA2DS2-VASc, LAVImax), (Figure 2).
Conclusion:In ATTR-CA LA remodeling is associated with TE irrespective of AF or CHA2DS2-VASc. Whereas AF and CHA2DS2-VASc are the main determinants of TE in other LVH phenotypes. These findings have potential implications to develop empirical anticoagulation strategies.
  • Ozbay, Benay  ( University of Pittsburgh Medical Center , Pittsburgh , Pennsylvania , United States )
  • Rearick, Corey  ( University of Pittsburgh Medical Center , Pittsburgh , Pennsylvania , United States )
  • Satyavolu, Bharadwaj  ( University of Pittsburgh Medical Center , Pittsburgh , Pennsylvania , United States )
  • Soman, Prem  ( University of Pittsburgh Medical Center , Pittsburgh , Pennsylvania , United States )
  • Wong, Timothy  ( University of Pittsburgh Medical Center , Pittsburgh , Pennsylvania , United States )
  • Azhar, Abdullah  ( University of Pittsburgh Medical Center , Pittsburgh , Pennsylvania , United States )
  • Katz, William  ( University of Pittsburgh Medical Center , Pittsburgh , Pennsylvania , United States )
  • Sade, Leyla Elif  ( University of Pittsburgh Medical Center , Pittsburgh , Pennsylvania , United States )
  • Author Disclosures:
    Benay Ozbay: DO NOT have relevant financial relationships | Corey Rearick: No Answer | Bharadwaj Satyavolu: DO NOT have relevant financial relationships | Prem Soman: DO have relevant financial relationships ; Advisor:Bridgebio:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Advisor:Specturm Dynamics:Active (exists now) ; Advisor:Pfizer:Active (exists now) ; Advisor:Alnylam:Active (exists now) | Timothy Wong: DO have relevant financial relationships ; Researcher:Bristol Myers Squibb:Active (exists now) ; Advisor:Cytokinetics:Active (exists now) ; Advisor:Bristol Myers Squibb:Active (exists now) ; Researcher:Tenaya:Active (exists now) ; Researcher:Cytokinetics:Active (exists now) | Abdullah Azhar: No Answer | William Katz: No Answer | Leyla Elif Sade: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Imaging the Sick Pump or the New Replacement Pump

Monday, 11/18/2024 , 12:50PM - 02:15PM

Moderated Digital Poster Session

More abstracts on this topic:
Abrupt cardiac rupture of the patient with ATTR amyloidosis

Tagata Kento, Yutaro Nomoto, Tao Koji, Kataoka Tetsuro, Ohishi Mitsuru


4-5 Years Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis:

Khan Muhammad Aslam, Haider Taimoor, Bhattarai Shraddha, Afzal Hafsa, Khan Bilal, Muhammad Anza, Shafique Nouman, Bhatia Hitesh, Aafreen Asna, Adil Abid Nawaz Khan, Akbar Usman, Khan Alamzaib, Haider Muhammad Adnan

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available